Answers are grounded in this paper and cite their sources.
Investigation reveals trace acetylcholinesterase in Cohn Fraction IV-4, indicating its role in cholinesterase research.
Cohn Fraction IV-4, a byproduct of the plasma fractionation process, is a rich source of human butyrylcholinesterase (BChE). We studied the possibility that the trace quantities of acetylcholinesterase (AChE) in human plasma might be in Fraction IV-4. We searched for AChE using a multi-layered approach including immunopurification, enzyme activity assays, and high-resolution mass spectrometry. BChE was immunodepleted from an extract of frozen Cohn Fraction IV-4, leaving active AChE in the supernatant at levels similar to AChE in Silent BChE plasma (devoid of BChE). AChE was captured by a monoclonal anti-AChE antibody. Tryptic peptides of the immunopurified AChE were subjected to LC-MS/MS analysis, resulting in the identification of eight AChE peptides that clearly distinguished AChE from BChE. Erythrocyte membrane-bound AChE and full length AChE have different C-terminal sequences. Peptide LLSATDTLDEAER is unique to full length AChE. Peptide LLSATDTLDEAER was found in AChE immunopurified from plasma-derived Cohn Fraction IV-4, supporting the conclusion that AChE in plasma and AChE in Cohn Fraction IV-4 originates mainly from tissues such as brain and muscle.
No takes yet. Share an insight, caveat, or question.
Önder et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: